Fresenius Kabi Oncology Ltd Stock
Equities
INE575G01010
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- INR | - |
2016 | AstraZeneca sells rights to anaesthetics for up to $770 million | RE |
2015 | Fresenius SE KGaA : Kabi sells German oncology compounding business | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-06-30 | |
Rahul Sharma
DFI | Director of Finance/CFO | - | - |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 08-08-10 | |
Director/Board Member | - | 07-07-20 | |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- Stock